Finance

Lists
Why is CRVO down 7.65%?
Dive Deeper
CRVO:NASDAQ
CervoMed Inc
$1.69
-7.65%
(-0.14) 1D
Nov 13, 4:00:01 PM GMT-5  ·   USD
All symbols
SymbolPriceChange% Change
Generating top insights for CRVO...
Open
$1.75
High
$1.79
Low
$1.64
Mkt. cap
25.57M
Avg. vol.
765.65K
Volume
640.38K
52-wk high
$10.00
52-wk low
$1.27
EPS
-$2.77
Beta
-0.62
Shares outstanding
15.13M
No. of employees
15
Open
$1.75
High
$1.79
Low
$1.64
Mkt. cap
25.57M
Avg. vol.
765.65K
Volume
640.38K
52-wk high
$10.00
52-wk low
$1.27
EPS
-$2.77
Beta
-0.62
Shares outstanding
15.13M
No. of employees
15
News stories
From web sources and news partners
About CervoMed Inc
CEO-
Employees15
Founded1995
HeadquartersBoston, Massachusetts, United States
SectorHealth Care
IndustryBiotechnology
Websitecervomed.com
Analyst ratings
Based on 4 analysts giving stock ratings to CRVO in the past 3 months
Strong buy
Buy
4
Hold
0
Sell
0
12-month forecast
Based on 4 Wall Street analysts offering 12 month price targets for CRVO in the last 3 months.
Highest
Current $1.69
$25.00 (+1,379.29%)
Average
$15.25 (+802.37%)
Lowest
$6.00 (+255.03%)
Analyst
Recommendation
Action
Price target
Projected
Date
Boris Peaker
JonesTrading
Buy
Maintained
$12.00
+610.1%
11/13/2026
Boobalan Pachaiyappan
Roth MKM
Buy
Maintained
$6.00
+255%
11/10/2026
Sumant Kulkarni
Canaccord Genuity
Buy
Reiterated
$18.00
+965.1%
11/10/2026
Ram Selvaraju
H.C. Wainwright
Buy
Reiterated
$25.00
+1,379.3%
11/09/2026
Daniil Gataulin
Chardan Capital
Buy
Reiterated
$21.00
+1,142.6%
05/17/2026
Soumit Roy
JonesTrading
Buy
Maintained
$20.00
+1,083.4%
04/06/2026
Previous reportsAll values in USD
Loading Previous Earnings...
Revenue
Net income
All values in USD
Dec 2025
Mar 2026
Jun 2026
Sep 2026
Revenue
8.73K
-
-
-
Cost of goods sold
5.83M
5.14M
4.32M
108.89K
Cost of revenue
5.83M
5.14M
4.32M
108.89K
Research and development expenses
-
-
-
3.57M
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
2.51M
2.98M
2.36M
2.43M
Operating expense
2.51M
2.98M
2.36M
6.00M
Total operating expenses
8.34M
8.11M
6.68M
6.10M
Operating income
-8.33M
-8.11M
-6.68M
-6.10M
Other non operating income
3.29K
-1.02K
2.00K
-970.00
EBT including unusual items
-8.09M
-7.96M
-6.57M
-5.90M
EBT excluding unusual items
-8.09M
-7.96M
-6.57M
-5.90M
Income tax expense
-
-
-
-
Effective tax rate
-
-
-
-
Other operating expenses
-
-
-
-
Net income
-8.09M
-7.96M
-6.57M
-5.90M
Net profit margin
-92,680.38%
-
-
-
Earnings per share
-0.88
-0.86
-0.64
-0.39
Interest and investment income
240.94K
147.39K
104.90K
210.49K
Interest expense
-
-
-
-
Net interest expenses
240.94K
147.39K
104.90K
210.49K
Depreciation and amortization charges
-
-
-
-
EBITDA
-
-
-
-
Gain or loss from assets sale
-
-
-
-
Insider transactions
Insider transactions data is drawn from third-party sources. Learn more
Insider
Position
Type
Date
Shares
Amount
Page 1
Upcoming events
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer
Google apps